246 related articles for article (PubMed ID: 8524814)
1. Phosphatidylinositol 3-kinase binding to polyoma virus middle tumor antigen mediates elevation of glucose transport by increasing translocation of the GLUT1 transporter.
Young AT; Dahl J; Hausdorff SF; Bauer PH; Birnbaum MJ; Benjamin TL
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11613-7. PubMed ID: 8524814
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of pp60c-src tyrosyl kinase activity in polyoma virus-infected mouse cells is closely associated with polyoma middle tumor antigen synthesis.
Bolen JB; Lewis AM; Israel MA
J Cell Biochem; 1985; 27(2):157-67. PubMed ID: 2580850
[TBL] [Abstract][Full Text] [Related]
3. Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro.
Auger KR; Carpenter CL; Shoelson SE; Piwnica-Worms H; Cantley LC
J Biol Chem; 1992 Mar; 267(8):5408-15. PubMed ID: 1372000
[TBL] [Abstract][Full Text] [Related]
4. Transformation by polyoma virus middle T antigen.
Courtneidge SA
Cancer Surv; 1986; 5(2):173-82. PubMed ID: 2430702
[TBL] [Abstract][Full Text] [Related]
5. Disruption of GLUT1 glucose carrier trafficking in L6E9 and Sol8 myoblasts by the phosphatidylinositol 3-kinase inhibitor wortmannin.
Kaliman P; Viñals F; Testar X; Palacín M; Zorzano A
Biochem J; 1995 Dec; 312 ( Pt 2)(Pt 2):471-7. PubMed ID: 8526858
[TBL] [Abstract][Full Text] [Related]
6. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc.
Dilworth SM; Brewster CE; Jones MD; Lanfrancone L; Pelicci G; Pelicci PG
Nature; 1994 Jan; 367(6458):87-90. PubMed ID: 7509037
[TBL] [Abstract][Full Text] [Related]
7. Transformation-defective polyoma middle T antigen mutants defective in PLCgamma, PI-3, or src kinase activation enhance ERK2 activation and promote retinoic acid-induced, cell differentiation like wild-type middle T.
Yen A; Cherington V; Schaffhausen B; Marks K; Varvayanis S
Exp Cell Res; 1999 May; 248(2):538-51. PubMed ID: 10222145
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-3-mediated cell survival signals include phosphatidylinositol 3-kinase-dependent translocation of the glucose transporter GLUT1 to the cell surface.
Bentley J; Itchayanan D; Barnes K; McIntosh E; Tang X; Downes CP; Holman GD; Whetton AD; Owen-Lynch PJ; Baldwin SA
J Biol Chem; 2003 Oct; 278(41):39337-48. PubMed ID: 12869574
[TBL] [Abstract][Full Text] [Related]
9. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation.
Whitman M; Kaplan DR; Schaffhausen B; Cantley L; Roberts TM
Nature; 1985 May 16-22; 315(6016):239-42. PubMed ID: 2987699
[TBL] [Abstract][Full Text] [Related]
10. Glucose deprivation induces Akt-dependent synthesis and incorporation of GLUT1, but not of GLUT4, into the plasma membrane of 3T3-L1 adipocytes.
von der Crone S; Deppe C; Barthel A; Sasson S; Joost HG; Schürmann A
Eur J Cell Biol; 2000 Dec; 79(12):943-9. PubMed ID: 11152285
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor induces phosphatidylinositol 3-kinase release from the middle T-pp60c-src complex and association with the platelet-derived growth factor receptor.
Zhang QX; Baldwin GS
Growth Factors; 1994; 10(1):41-51. PubMed ID: 7514012
[TBL] [Abstract][Full Text] [Related]
12. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells.
Hara K; Yonezawa K; Sakaue H; Ando A; Kotani K; Kitamura T; Kitamura Y; Ueda H; Stephens L; Jackson TR
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7415-9. PubMed ID: 8052599
[TBL] [Abstract][Full Text] [Related]
13. Insulin and insulin-like growth factor I (IGF-I) stimulate GLUT4 glucose transporter translocation in Xenopus oocytes.
Mora S; Kaliman P; Chillarón J; Testar X; Palacín M; Zorzano A
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):59-65. PubMed ID: 7575481
[TBL] [Abstract][Full Text] [Related]
14. Association of impaired phosphatidylinositol 3-kinase activity in GLUT1-containing vesicles with malinsertion of glucose transporters into the plasma membrane of fibroblasts from a patient with severe insulin resistance and clinical features of Werner syndrome.
Kausch C; Hamann A; Uphues I; Niendorf A; Müller-Wieland D; Joost HG; Algenstaedt P; Dreyer M; Rüdiger HW; Häring HU; Eckel J; Matthaei S
J Clin Endocrinol Metab; 2000 Feb; 85(2):905-18. PubMed ID: 10690909
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional modification of pp60c-src associated with polyoma middle tumor antigen from infected or transformed cells.
Cartwright CA; Hutchinson MA; Eckhart W
Mol Cell Biol; 1985 Oct; 5(10):2647-52. PubMed ID: 2426573
[TBL] [Abstract][Full Text] [Related]
16. The catalytic subunit of phosphatidylinositol 3-kinase is a substrate for the activated platelet-derived growth factor receptor, but not for middle-T antigen-pp60c-src complexes.
Roche S; Dhand R; Waterfield MD; Courtneidge SA
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):703-11. PubMed ID: 7519847
[TBL] [Abstract][Full Text] [Related]
17. An 81 kd protein complexed with middle T antigen and pp60c-src: a possible phosphatidylinositol kinase.
Courtneidge SA; Heber A
Cell; 1987 Sep; 50(7):1031-7. PubMed ID: 2441879
[TBL] [Abstract][Full Text] [Related]
18. Phosphoinositide kinase activity and transformation.
Whitman M; Kaplan D; Cantley L; Roberts TM; Schaffhausen B
Fed Proc; 1986 Oct; 45(11):2647-52. PubMed ID: 3019785
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation.
Bolen JB; Thiele CJ; Israel MA; Yonemoto W; Lipsich LA; Brugge JS
Cell; 1984 Oct; 38(3):767-77. PubMed ID: 6091900
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin.
Clarke JF; Young PW; Yonezawa K; Kasuga M; Holman GD
Biochem J; 1994 Jun; 300 ( Pt 3)(Pt 3):631-5. PubMed ID: 8010944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
